ITRI NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Itron Inc · Technology · Scientific & Technical Instruments

Open interactive chart View report data
Latest close 99.66 USD
18.3% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is 11.2% above the Trend Line and sits at 34.1% of its 52-week range. The latest completed week returned 18.3%, after a 17.1% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is neither clearly cheap nor expensive. Options positioning is bearish with 54/100 conviction, while the latest news-sentiment score is 60/100.

Setup score 51 out of 100
Latest Close 99.66 USD 31 Jul 2026
1W Return 18.3% latest completed week
4W Return 17.1% short-term follow-through
12W Return 21.7% quarterly tape
Trend Breadth 23.1% 12 of 52 weeks active
Volume Ratio 3.6x vs 13-week average
What is working
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
  • Volume is elevated versus the 13-week average, confirming attention.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 18.3% Latest completed week; four-week move 17.1%. Indicator stack 13/86 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Bearish 54/100 conviction; expected move 17.9%. News sentiment 60/100 57 relevant articles in the latest sentiment read. Event risk 30 Jul Latest stored earnings date was 30 Jul 2026.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 11.2% above the Trend Line and sits at 34.1% of its 52-week range. The latest completed week returned 18.3%, after a 17.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 3.6x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0912-week average 0.03

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.09Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 17.1% over four weeks, 21.7% over 12 weeks, and -19.1% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W18.3%
4W17.1%
12W21.7%
26W0.6%
52W-19.1%
Active trend streak0 weeks
Active weeks in one year12
Trend breadth23.1%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.62Latest activity-pressure read.
Pressure change310.7%Four-week change in activity pressure.
Leadership-9.22Latest relative-leadership reading.
RS change68.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 94% Model confidence 90%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength76/100Blend of value, momentum, and quality. Underlying universe rank 25; rank 1 is best.
Value79/100Relative valuation strength. Underlying universe rank 22; rank 1 is best.
Quality83/100Profitability and accounting quality. Underlying universe rank 18; rank 1 is best.
Momentum9/100Medium-term price momentum. Underlying universe rank 92; rank 1 is best.
Growth21/100Revenue and earnings growth. Underlying universe rank 80; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework71/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
12.9x
Price divided by trailing earnings.
Price / sales
1.6x
Market value relative to trailing revenue.
EV / EBITDA
11.3x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
9.5%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
38.8%
Gross profit retained from each unit of revenue.
Operating margin
15.1%
Operating profit retained from revenue.
Free-cash-flow margin
18.8%
Free cash flow generated from revenue.
Return on invested capital
12.6%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-4.0%
Latest one-year revenue growth.
EPS growth
14.3%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
45.0%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
5.2%
Net share repurchases relative to market value.
Shareholder yield
5.2%
Dividend yield plus net buyback yield.
Net debt / EBITDA
2.2x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBearish

ITRI shows bearish options pressure with a 54/100 conviction score, put-call volume ratio of 4.48, expected move of 17.9%, and Sharemaestro trend signal inactive.

Conviction55/100
Expected move17.9%
Put/call volume4.48
Pressure-66
Speculation12
Volatility66
Trend agreement67
Open options detail
Insider activity7 / 13

7 acquisitions and 13 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment60/100

Weighted news tone is neutral across 57 relevant articles.

24 positive · 29 neutral · 4 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings30 JulLatest stored earnings date was 30 Jul 2026.
Options expected move17.9%Nearest-chain priced movement where available.
52-week drawdown-29.8%Distance below the 52-week high.
13-week volatility5.5%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+18.3%Week of 31 Jul.
Worst week-14.1%Week of 13 Feb.
Latest week+18.3%Week of 31 Jul.

Shape of recent returns

Strong gains6
Modest gains7
Flat weeks0
Modest losses8
Sharp losses5
Recent vol5.5%13-week weekly-return volatility.
Base vol6.1%52-week weekly-return volatility.
Up/down split28/24Count of positive and negative weeks in the 52-week window.
Average skew3.5% / -4.5%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape42/100

Trend, activity pressure, participation, and risk combine to a 42/100 tape read.

 Indicator analysis17/100

Latest 12-week confirmation: trend 0/12, activity pressure 4/12, relative leadership 0/12.

Activity pressure 0.09; No reversal markers Factors63/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 11; Small Cap Core rank 25 SVQF71/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 212.0 of 726 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options42/100

ITRI shows bearish options pressure with a 54/100 conviction score, put-call volume ratio of 4.48, expected move of 17.9%, and Sharemaestro trend signal inactive.

Bearish · Put-side pressure · Expected move 17.9% Sentiment60/100

Weighted news tone is neutral across 57 relevant articles.

Wall Street Analysts Believe Itron (ITRI) Could Rally 25.09%: Here's is How to Trade Insiders7 / 13

7 acquisitions and 13 disposals in the latest 180-day insider tape.

 Earnings30 Jul

Latest stored earnings date was 30 Jul 2026.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202699.66 USD18.3%89.61 USD97.38 USD0.62-9.2214.0MOff
24 Jul 202684.22 USD-2.1%89.44 USD97.20 USD0.25-23.582.8MOff
17 Jul 202685.99 USD1.0%89.85 USD97.15 USD0.26-24.292.1MOff
10 Jul 202685.10 USD-0.0%90.19 USD97.09 USD0.03-29.192.3MOff
3 Jul 202685.11 USD1.5%90.56 USD97.00 USD-0.29-28.942.7MOff
26 Jun 202683.87 USD3.8%90.98 USD96.90 USD-0.66-30.374.2MOff
19 Jun 202680.81 USD0.3%91.49 USD96.83 USD-0.96-36.823.1MOff
12 Jun 202680.56 USD0.6%91.99 USD96.74 USD-0.98-36.282.7MOff
5 Jun 202680.07 USD-2.9%92.58 USD96.69 USD-1.05-36.053.2MOff
29 May 202682.48 USD-0.7%93.42 USD96.64 USD-1.00-37.872.6MOff
22 May 202683.02 USD4.8%94.02 USD96.55 USD-0.71-36.413.6MOff
15 May 202679.24 USD-3.2%95.78 USD96.44 USD-0.52-39.253.6MOff
8 May 202681.87 USD-4.1%97.52 USD96.37 USD-0.09-38.143.5MOff
1 May 202685.40 USD-3.6%98.86 USD96.27 USD0.16-32.688.5MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.